·
2 Min Read

AMA applauds FDA's approval of second OTC naloxone product

The AMA has long advocated for improved access to OTC naloxone as the deadly drug overdose epidemic continues to devastate communities.

Press Releases
Figure in a virtual meeting
·
3 Min Read

Help your resident physicians meet new DEA training mandate

Easily assign and track an AMA-curated collection of courses to help residents prevent drug-overdose deaths and comply with training requirements.

series
Improve GME
Transitioning to Practice
2023 Annual Meeting delegates from Kansas and Missouri
·
4 Min Read

Put naloxone in schools so it can save lives

Opioid overdose-reversing drugs such as naloxone save lives. They should be available in educational settings and public areas, the AMA says.

Behavioral Health
Narcan nasal spray
·
4 Min Read

Narcan lands OTC approval: What it means for patients, doctors

The drug’s manufacturer and retailers must help ensure the lifesaving opioid overdose-reversal medication is widely available at an affordable price. 

Behavioral Health
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update
·
11 Min Read

Naloxone: FDA approves over-the-counter Narcan nasal spray with Bobby Mukkamala, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about Narcan, the over-the-counter naloxone nasal spray, and more.

series
Behavioral Health
AMA Update Podcast
Katherine Pannel, DO
·
6 Min Read

How this DO’s advocacy will help prevent drug-overdose deaths

AMA member Katherine Pannel, DO, helped persuade lawmakers to decriminalize fentanyl test strips in Mississippi. Learn more.

Behavioral Health
·
3 Min Read

AMA launches resource to help physicians meet DEA training requirement

The AMA Ed Hub™ has a new educational webpage for physicians to complete required training on treating patients with opioid or other substance use disorders.

Press Releases
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of March 27, 2023

In the news: FDA rule on salt substitutes, undiagnosed atrial fibrillation in the U.S., Narcan (naloxone) to be available over the counter and more.

Publications & Newsletters